New prognostic marker identified for gastric cancer recurrence risk

FHS
July 30, 2024
2:28 pm

Surgical removal of the tumor is considered the basis for curing gastric cancer. However, 40 per cent of patients who have undergone surgery suffer a relapse within two years.

Newcells Biotech appoints Emile Shaffu as Director of Sales

Newcells Biotech, a leading drug discovery partner specializing in developing in vitro models and bespoke assay services to improve the prediction of in vivo human

July 9, 2024

Widespread inhaler misuse in COPD patients: Need for training

Study found that 69% of hospitalized COPD patients misused inhalers, with 66% making critical errors, and 14% having insufficient Peak Inspiratory Flow (PIF), even after

August 25, 2024

A new RSV shot could help protect babies this winter — if they can get it in time

Emily Bendt was in her third trimester of pregnancy when she first heard the Centers for Disease Control and Prevention had approved a new shot

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.